$26.78
-0.14-0.52%
At close: -
$26.75
-0.03-0.11%
After Hours: 7:37 PM EDT
Comments
Loading...
Lemonade Analyst Ratings and Price Targets | NYSE:LMND | Benzinga
Lemonade Inc has a consensus price target of $30.38 based on the ratings of 14 analysts. The high is $60 issued by Citizens Capital Markets on February 26, 2025. The low is $12 issued by B of A Securities on May 4, 2023. The 3 most-recent analyst ratings were released by Morgan Stanley, Piper Sandler, and Citizens Capital Markets on April 8, 2025, February 26, 2025, and February 26, 2025, respectively. With an average price target of $39.33 between Morgan Stanley, Piper Sandler, and Citizens Capital Markets, there's an implied 47.04% upside for Lemonade Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Morgan Stanley
Piper Sandler
Citizens Capital Markets
JMP Securities
BMO Capital
1calculated from analyst ratings
Analyst Ratings for Lemonade
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 04/08/2025 | Buy Now | -10.28% | Morgan Stanley | Bob Huang72% | $35 → $24 | Downgrade | Equal-Weight → Underweight | Get Alert |
| 02/26/2025 | Buy Now | 27.1% | Piper Sandler | Arvind Ramnani54% | $44 → $34 | Maintains | Neutral | Get Alert |
| 02/26/2025 | Buy Now | 124.3% | Citizens Capital Markets | Andrew Boone73% | $60 → $60 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 11/22/2024 | Buy Now | 124.3% | JMP Securities | Ronald Josey70% | $40 → $60 | Maintains | Market Outperform | Get Alert |
| 11/21/2024 | Buy Now | -43.93% | BMO Capital | Michael Zaremski73% | $13 → $15 | Maintains | Underperform | Get Alert |
| 11/21/2024 | Buy Now | 64.49% | Piper Sandler | Arvind Ramnani54% | $25 → $44 | Maintains | Neutral | Get Alert |
| 11/20/2024 | Buy Now | 57.01% | Morgan Stanley | Michael Phillips57% | $23 → $42 | Upgrade | Underweight → Equal-Weight | Get Alert |
| 11/15/2024 | Buy Now | -14.02% | Morgan Stanley | Michael Phillips57% | $15 → $23 | Maintains | Underweight | Get Alert |
| 11/07/2024 | Buy Now | -21.5% | Keefe, Bruyette & Woods | Thomas McJoynt-Griffith74% | $18 → $21 | Downgrade | Market Perform → Underperform | Get Alert |
| 11/01/2024 | Buy Now | -6.54% | Piper Sandler | Arvind Ramnani54% | $18 → $25 | Maintains | Neutral | Get Alert |
| 10/15/2024 | Buy Now | 49.53% | JMP Securities | Karol Chmiel77% | $40 → $40 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 10/09/2024 | Buy Now | -47.66% | Jefferies | Yaron Kinar75% | $15 → $14 | Maintains | Underperform | Get Alert |
| 05/07/2024 | Buy Now | -40.19% | Jefferies | Yaron Kinar75% | $14 → $16 | Maintains | Underperform | Get Alert |
| 05/02/2024 | Buy Now | -32.71% | Piper Sandler | Arvind Ramnani54% | $17 → $18 | Maintains | Neutral | Get Alert |
| 04/15/2024 | Buy Now | 49.53% | JMP Securities | Karol Chmiel77% | $40 → $40 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 03/04/2024 | Buy Now | -32.71% | Keefe, Bruyette & Woods | Thomas McJoynt-Griffith74% | $16 → $18 | Maintains | Market Perform | Get Alert |
| 02/29/2024 | Buy Now | -36.45% | Piper Sandler | Arvind Ramnani54% | → $17 | Reiterates | Neutral → Neutral | Get Alert |
| 02/28/2024 | Buy Now | -47.66% | Morgan Stanley | Michael Phillips57% | $13 → $14 | Maintains | Underweight | Get Alert |
| 12/01/2023 | Buy Now | — | Oppenheimer | Jason Helfstein78% | — | Downgrade | Outperform → Perform | Get Alert |
| 11/07/2023 | Buy Now | -55.14% | Morgan Stanley | Michael Phillips57% | $11 → $12 | Maintains | Underweight | Get Alert |
| 11/02/2023 | Buy Now | -58.88% | Morgan Stanley | Michael Phillips57% | $10 → $11 | Maintains | Underweight | Get Alert |
| 10/11/2023 | Buy Now | -62.62% | Morgan Stanley | Michael Phillips57% | $15 → $10 | Maintains | Underweight | Get Alert |
| 09/28/2023 | Buy Now | -66.36% | BMO Capital | Michael Zaremski73% | $8 → $9 | Maintains | Underperform | Get Alert |
| 08/04/2023 | Buy Now | -36.45% | Piper Sandler | Arvind Ramnani54% | $18 → $17 | Maintains | Neutral | Get Alert |
| 08/03/2023 | Buy Now | -43.93% | Morgan Stanley | Michael Phillips57% | $14 → $15 | Maintains | Underweight | Get Alert |
| 07/12/2023 | Buy Now | 49.53% | JMP Securities | Karol Chmiel77% | → $40 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 06/20/2023 | Buy Now | -47.66% | Morgan Stanley | Michael Phillips57% | → $14 | Initiates | → Underweight | Get Alert |
| 05/09/2023 | Buy Now | -36.45% | Barclays | Tracy Benguigui61% | $16 → $17 | Maintains | Equal-Weight | Get Alert |
| 05/05/2023 | Buy Now | -32.71% | Piper Sandler | Arvind Ramnani54% | → $18 | Reiterates | → Neutral | Get Alert |
| 05/04/2023 | Buy Now | -55.14% | B of A Securities | Joshua Shanker75% | $14 → $12 | Maintains | Underperform | Get Alert |
| 05/04/2023 | Buy Now | 49.53% | JMP Securities | Karol Chmiel77% | → $40 | Reiterates | → Market Outperform | Get Alert |
| 04/18/2023 | Buy Now | 49.53% | JMP Securities | Matthew Carletti83% | → $40 | Reiterates | → Market Outperform | Get Alert |
| 04/10/2023 | Buy Now | -57.01% | Jefferies | Yaron Kinar75% | $13 → $11.5 | Maintains | Underperform | Get Alert |
| 02/24/2023 | Buy Now | -40.19% | Barclays | Ross Sandler69% | $18 → $16 | Maintains | Equal-Weight | Get Alert |
| 02/24/2023 | Buy Now | -32.71% | Piper Sandler | Arvind Ramnani54% | $19 → $18 | Maintains | Neutral | Get Alert |
| 01/20/2023 | Buy Now | -62.62% | BMO Capital | Michael Zaremski73% | → $10 | Initiates | → Underperform | Get Alert |
| 01/18/2023 | Buy Now | -28.97% | Piper Sandler | Arvind Ramnani54% | $20 → $19 | Maintains | Neutral | Get Alert |
| 11/17/2022 | Buy Now | -10.28% | Keefe, Bruyette & Woods | Thomas McJoynt-Griffith74% | → $24 | Initiates | → Market Perform | Get Alert |
| 11/10/2022 | Buy Now | -32.71% | Barclays | Tracy Benguigui61% | $28 → $18 | Maintains | Equal-Weight | Get Alert |
| 11/10/2022 | Buy Now | -25.23% | Piper Sandler | Arvind Ramnani54% | $25 → $20 | Maintains | Neutral | Get Alert |
| 08/10/2022 | Buy Now | 4.67% | Barclays | Tracy Benguigui61% | $20 → $28 | Maintains | Equal-Weight | Get Alert |
| 08/10/2022 | Buy Now | -6.54% | Piper Sandler | Arvind Ramnani54% | $20 → $25 | Maintains | Neutral | Get Alert |
| 07/18/2022 | Buy Now | -25.23% | Piper Sandler | Arvind Ramnani54% | $24 → $20 | Downgrade | Overweight → Neutral | Get Alert |
| 05/13/2022 | Buy Now | -25.23% | Barclays | Tracy Benguigui61% | $22 → $20 | Maintains | Equal-Weight | Get Alert |
| 05/11/2022 | Buy Now | 12.15% | Oppenheimer | Jason Helfstein78% | $45 → $30 | Maintains | Outperform | Get Alert |
| 05/11/2022 | Buy Now | 49.53% | JMP Securities | Matthew Carletti83% | $95 → $40 | Maintains | Market Outperform | Get Alert |
| 05/11/2022 | Buy Now | -10.28% | Piper Sandler | Arvind Ramnani54% | $32 → $24 | Maintains | Overweight | Get Alert |
FAQ
What is the target price for Lemonade (LMND) stock?
The latest price target for Lemonade (NYSE:LMND) was reported by Morgan Stanley on April 8, 2025. The analyst firm set a price target for $24.00 expecting LMND to fall to within 12 months (a possible -10.28% downside). 14 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Lemonade (LMND)?
The latest analyst rating for Lemonade (NYSE:LMND) was provided by Morgan Stanley, and Lemonade downgraded their underweight rating.
When was the last upgrade for Lemonade (LMND)?
The last upgrade for Lemonade Inc happened on November 20, 2024 when Morgan Stanley raised their price target to $42. Morgan Stanley previously had an underweight for Lemonade Inc.
When was the last downgrade for Lemonade (LMND)?
The last downgrade for Lemonade Inc happened on April 8, 2025 when Morgan Stanley changed their price target from $35 to $24 for Lemonade Inc.
When is the next analyst rating going to be posted or updated for Lemonade (LMND)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Lemonade, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Lemonade was filed on April 8, 2025 so you should expect the next rating to be made available sometime around April 8, 2026.
Is the Analyst Rating Lemonade (LMND) correct?
While ratings are subjective and will change, the latest Lemonade (LMND) rating was a downgraded with a price target of $35.00 to $24.00. The current price Lemonade (LMND) is trading at is $26.75, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
